[Advances in IgG4-related hypertrophic pachymeningitis]

L N Wu; D H Lu; Y S Piao

doi:10.3760/cma.j.cn112138-20220908-00668

[Advances in IgG₄-related hypertrophic pachymeningitis]

Zhonghua Nei Ke Za Zhi. 2023 Sep 1;62(9):1139-1143. doi: 10.3760/cma.j.cn112138-20220908-00668.

[Article in Chinese]

Authors

L N Wu¹, D H Lu¹, Y S Piao¹

Affiliation

¹ Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.

PMID: 37650189
DOI: 10.3760/cma.j.cn112138-20220908-00668

Abstract

IgG₄相关性硬脑膜炎（IgG₄-RHP）过去很大一部分被归入特发性肥厚性硬脑膜炎，现已证实IgG₄-RHP实际为IgG₄相关性疾病，一旦确诊应用糖皮质激素会使病情得到显著缓解。临床实践中，IgG₄-RHP诊断困难、误诊及漏诊率较高，本文对IgG₄-RHP相关研究进展作一综述，以期提高临床医生对IgG₄-RHP的理解及认识。.

MeSH terms

Humans
Hypertrophy
Immunoglobulin G*

Substances

Immunoglobulin G